Maxcyte Inc (MXCT)
$1.59 -8.09% Close Oct 30, 2026 Live
Maxcyte stock today
Maxcyte closed at $1.59 on October 30, 2026, down 8.09% on the day. Over the past year it returned +5.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $170 million.
$1.00$1.50
NovJan 2026MarMayJulSep
| Period | MXCT | S&P 500 (SPY) |
|---|---|---|
| 1 month | +42.0% | -0.9% |
| 3 months | +51.4% | +2.1% |
| Year to date | +2.6% | +11.7% |
| 1 year | +5.3% | +12.4% |
| 3 years | -46.3% | +88.5% |
| 5 years | -85.9% | +76.0% |
Key statistics
- Market value
- $170M
- Price / sales
- 5.5
- 52-week range
- $0.68 to $1.76
- Next report
- Nov 10, 2026
About Maxcyte
Biotechnology company developing cell therapy technologies and manufacturing solutions.
Sector: Health Care
More on Maxcyte
- Financials: revenue, earnings and segmentsRevenue -15% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $141.46 today
No forecast, no recommendation. This page describes Maxcyte Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.